Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study

Biomedicine and Pharmacotherapy

Volumn 71, Issue , 2015, Pages 210-215

  Shi, Huichang ^a   Han, Jun ^a   Yue, Shun ^a   Zhang, Tiecheng ^a   Zhu, Weiguo ^a   Zhang, Dahong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CyclinD2; Gastric cancer; Microrna 206; Prognosis; Quantitative real time polymerase chain reaction

Indexed keywords

CYCLIN D2; MESSENGER RNA; MICRORNA; MICRORNA 206; UNCLASSIFIED DRUG; CCND2 PROTEIN, HUMAN; MIRN206 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; DOWN REGULATION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; RNA EXTRACTION; STOMACH CANCER; STOMACH MUCOSA; TUMOR INVASION; UPREGULATION; AGED; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIVARIATE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CYCLIN D2; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84928944480     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.037     Document Type: Article

References (32)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Zhang Y.Z., Zhang L.H., Gao Y., Li C.H., Jia S.Q., Liu N., et al. Discovery and validation of prognostic markers in gastric cancer by genome-wide expression profiling. World J Gastroenterol 2011, 17:1710-1717.
3. Ye Y.W., Dong R.Z., Zhou Y., Du C.Y., Wang C.M., Fu H., et al. Prognostic analysis of familial gastric cancer in Chinese population. J Surg Oncol 2011, 104:76-82.
4. Wang C.S., Hsieh C.C., Chao T.C., Jan Y.Y., Jeng L.B., Hwang T.L., et al. Resectable gastric cancer: operative mortality and survival analysis. Chang Gung Med J 2002, 25:216-227.
5. Cervantes A., Rodríguez Braun E., Pérez Fidalgo A., Chirivella González I. Molecular biology of gastric cancer. Clin Transl Oncol 2007, 9:208-215.
6. Yang W., Raufi A., Klempner S.J. Targeted therapy for gastric cancer: molecular pathways and ongoing investigations. Biochim Biophys Acta 2014, 1846:232-237.
7. Huang J.T., Wang J., Srivastava V., Sen S., Liu S.M. MicroRNA machinery genes as novel biomarkers for cancer. Front Oncol 2014, 4:113.
8. Palanichamy J.K., Rao D.S. miRNA dysregulation in cancer: towards a mechanistic understanding. Front Genet 2014, 5:54.
9. Uozaki H., Morita S., Kumagai A., Aso T., Soejima Y., Takahashi Y., et al. Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. Histopathology 2014, 65:775-783.
10. Tsujiura M., Komatsu S., Ichikawa D., Shiozaki A., Konishi H., Takeshita H., et al. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer 2015, 18:271-279.
11. Zhou X., Xia Y., Su J., Zhang G. Downregulation of miR-141 induced by Helicobacter pylori promotes the invasion of gastric cancer by targeting STAT4. Cell Physiol Biochem 2014, 33:1003-1012.
12. Fei B., Wu H. MiR-378 inhibits progression of human gastric cancer MGC-803 cells by targeting MAPK1 in vitro. Oncol Res 2012, 20:557-564.
13. Elliman S.J., Howley B.V., Mehta D.S., Fearnhead H.O., Kemp D.M., Barkley L.R. Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers. Oncogenesis 2014, 3:e113.
14. Missiaglia E., Shepherd C.J., Patel S., Thway K., Pierron G., Pritchard-Jones K., et al. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer 2010, 102:1769-1777.
15. Georgantas R.W., Streicher K., Luo X., Greenlees L., Zhu W., Liu Z., et al. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. Pigment Cell Melanoma Res 2014, 27:275-286.
16. Zhou J., Tian Y., Li J., Lu B., Sun M., Zou Y., et al. miR-206 is downregulated in breast cancer and inhibits cell proliferation through the upregulation of cyclinD2. Biochem Biophys Res Commun 2014, 433:207-212.
17. Zhang T., Liu M., Wang C., Lin C., Sun Y., Jin D. Downregulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 2011, 31:3859-3863.
18. Li S., Li Y., Wen Z., Kong F., Guan X., Liu W. microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor α-positive ovarian cancer cells. Mol Med Rep 2014, 9:1703-1708.
19. Yang Q., Zhang C., Huang B., Li H., Zhang R., Huang Y., et al. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur J Gastroenterol Hepatol 2013, 25:953-957.
20. Chen X., Yan Q., Li S., Zhou L., Yang H., Yang Y., et al. Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma. Cancer Lett 2012, 314:41-53.
21. Song G., Zhang Y., Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009, 284:31921-31927.
22. Ren J., Huang H.J., Gong Y., Yue S., Tang L.M., Cheng S.Y. MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci 2014, 4:26.
23. Zhang L., Liu X., Jin H., Guo X., Xia L., Chen Z., et al. miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett 2013, 332:94-101.
24. Zhang T.C., Zhu W.G., Huang M.D., Fan R.H., Chen X.F. Prognostic value of ADAM17 in human gastric cancer. Med Oncol 2012, 29:2684-2690.
25. Tsai M.M., Wang C.S., Tsai C.Y., Chi H.C., Tseng Y.H., Lin K.H. Potential prognostic, diagnostic and therapeutic markers for human gastric cancer. World J Gastroenterol 2014, 20:13791-13803.
26. Wang X., Ling C., Bai Y., Zhao J. MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec (Hoboken) 2011, 294:88-92.
27. Liu W., Xu C., Wan H., Liu C., Wen C., Lu H., et al. MicroRNA-206 overexpression promotes apoptosis, induces cell cycle arrest and inhibits the migration of human hepatocellular carcinoma HepG2 cells. Int J Mol Med 2014, 34:420-428.
28. Wang J., Tsouko E., Jonsson P., Bergh J., Hartman J., Aydogdu E., et al. miR-206 inhibits cell migration through direct targeting of the actin-binding protein Coronin 1C in triple-negative breast cancer. Mol Oncol 2014, 8:1690-1702.
29. Li Y., Hong F., Yu Z. Decreased expression of microRNA-206 in breast cancer and its association with disease characteristics and patient survival. J Int Med Res 2013, 41:596-602.
30. Lin F., Yao L., Xiao J., Liu D., Ni Z. MiR-206 functions as a tumor suppressor and directly targets K-Ras in human oral squamous cell carcinoma. Onco Targets Ther 2014, 7:1583-1591.
31. Zhang C., Yao C., Li H., Wang G., He X. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma. Int J Clin Exp Pathol 2014, 7:4194-4203.
32. Wang S., Lu S., Geng S., Ma S., Liang Z., Jiao B. Decreased expression of microRNA-206 correlates with poor clinical outcome in patients with malignant astrocytomas. Pathol Oncol Res 2014, [In press].